Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01176045 · ClinicalTrials.gov registry record

TearLab Refractive Surgery Dry Eye Study

A clinical trial of Dry Eye Syndromes, sponsored by TearLab Corporation.

Completed
Registry status
128
Enrollment target
8
Study locations

NCT01176045 is a study of Dry Eye Syndromes that has completed, run by TearLab Corporation. The registered enrollment target is 128 participants, below the 407-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (69% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01176045, a study of Dry Eye Syndromes, has completed, sponsored by TearLab Corporation.

COMPLETED
Registry status
128 participants
Enrollment target
8
Study locations

Study Summary

The primary objective of this study is to determine how pre \& post-operative tear osmolarity levels relate to rates of dry eye symptoms related to refractive surgery and if differences exist in patients who are pre-treated with ocular lubricants vs. those treated only post-operatively.

Conditions Studied

Study Locations (8)

Oklahoma

  • Oklahoma City TLC - Oklahoma City
  • Tulsa TLC - Tulsa

Connecticut

  • Connecticut TLC - Fairfield

Illinois

  • Westchester TLC - Westchester

Pennsylvania

  • Kremer Eye Center - King of Prussia

Texas

  • San Antonio TLC - San Antonio

Utah

  • Salt Lake City TLC - Salt Lake City

Virginia

  • Reston TLC - Reston

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2010-06
Est. Completion 2011-12

Sponsor

TearLab Corporation

4 total trials

What the Registry Record Tells You About NCT01176045

The ClinicalTrials.gov registry entry for NCT01176045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 407-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (69% lower). The listed sponsor is TearLab Corporation, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Eye Syndromes appearing as the primary indexed condition, and to 0 interventions.

NCT01176045 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Oklahoma, Connecticut, Illinois.

Frequently Asked Questions

What is clinical trial NCT01176045 about?

NCT01176045 is a clinical study titled "TearLab Refractive Surgery Dry Eye Study". The primary objective of this study is to determine how pre \& post-operative tear osmolarity levels relate to rates of dry eye symptoms related to refractive surgery and if differences exist in patients who are pre-treated with ocular lubricants vs. those treated only post-operatively.

What is the current status of trial NCT01176045?

This trial is currently completed. The enrollment target is 128 participants. The study started on 2010-06. Estimated completion is 2011-12.

What conditions does trial NCT01176045 study?

This clinical trial studies the following conditions: Dry Eye Syndromes.

Who is sponsoring clinical trial NCT01176045?

This trial is sponsored by TearLab Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01176045 being conducted?

This trial has 8 study locations across Connecticut, Illinois, Oklahoma, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dry Eye Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.